254 results on '"O'Toole, Sharon A"'
Search Results
2. Assessing circulating tumour DNA (ctDNA) as a prognostic biomarker in locally advanced rectal cancer: a systematic review and meta-analysis
3. Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma
4. Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression
5. Ex vivo expansion of circulating tumour cells (CTCs)
6. Biobanking rare gynaecological tumours – How harmonised is data collection?
7. P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer
8. Circulating tumour cells: The Good, the Bad and the Ugly
9. Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer
10. The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenon
11. Assessing Circulating Tumour DNA (ctDNA) as a Biomarker for Anal Cancer Management: A Systematic Review
12. Influenza A virus causes maternal and fetal pathology via innate and adaptive vascular inflammation in mice
13. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status
14. Exposure to tobacco smoke measured by urinary nicotine metabolites increases risk of p16/Ki-67 co-expression and high-grade cervical neoplasia in HPV positive women: A two year prospective study
15. A risk score for prediction of venous thromboembolism in gynecologic cancer: The Thrombogyn score
16. Expression quantitative trait locus fine mapping of the 17q12–21 asthma locus in African American children: a genetic association and gene expression study
17. Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy
18. P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer
19. Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?
20. Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy
21. FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer
22. Assessing circulating tumour DNA (ctDNA) as a prognostic biomarker in locally advanced rectal cancer: a systematic review and meta-analysis.
23. #836 Liquid biopsy isolation of circulating tumour cells from epithelial ovarian cancer patients and their prognostic significance
24. Ovarian Cancer Chemoresistance
25. Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1
26. Performance of the HPV E6/E7 mRNA Aptima HPV assay combined with partial genotyping compared with the HPV DNA Cobas 4800 HPV test for use in primary screening: Results from the CERVIVA HPV primary screening study in Ireland.
27. Dynamic interplay between sortilin and syndecan-1 drives a metabolic switch during prostate cancer progression
28. A novel serum microRNA panel to discriminate benign from malignant ovarian disease
29. Non-invasive and non-destructive measurements of confluence in cultured adherent cell lines
30. Co-designing resources to support the transition from child to adult health services for young people with cerebral palsy: A design thinking approach
31. The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma
32. Influenza A virus elicits peri-vascular adipose tissue inflammation and vascular dysfunction of the aorta in pregnant mice
33. Ex Vivo Expansion of Circulating Tumour Cells (CTCs)
34. Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer- relationship with venous thrombosis risk
35. Ovarian Cancer Chemoresistance
36. Epitope presentation is an important determinant of the utility of antigens identified from protein arrays in the development of autoantibody diagnostic assays
37. A Case with Genetic Linkage to a Child Born over Seventeen Years Prior, Successfully Treated with Surgery and Pembrolizumab
38. Harmonising the human biobanking consent process: an Irish experience
39. Epithelioid Trophoblastic Tumour: A Case with Genetic Linkage to a Child Born over Seventeen Years Prior, Successfully Treated with Surgery and Pembrolizumab
40. Noninvasive Early Biomarkers in Ovarian Cancer
41. Lncrna mort (Znf667-as1) in cancer—is there a possible role in gynecological malignancies?
42. Harmonising the human biobanking consent process: an Irish experience
43. Carboplatin and taxol resistance develops more rapidly in functional BRCA1 compared to dysfunctional BRCA1 ovarian cancer cells
44. Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma
45. The Use of MYBL2 as a Novel Candidate Biomarker of Cervical Cancer
46. Ovarian Cancer Chemoresistance
47. LncRNA MORT (ZNF667-AS1) in Cancer—Is There a Possible Role in Gynecological Malignancies?
48. An Overview of the Role of Long Non-Coding RNAs in Human Choriocarcinoma
49. Modern strategies to improve diagnosis and treatment of rare gynecologic tumors—current challenges and future directions
50. Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.